An observational study in Neovascular Glaucoma, sponsored by Zhongnan Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Zhongnan Hospital · Observational
This study primarily involved a retrospective analysis of clinical and follow-up data from patients with advanced neovascular glaucoma who underwent minimally invasive suprachoroidal drainage surgery at the Department of Ophthalmology, Zhongnan Hospital of Wuhan University, to evaluate the safety and efficacy of this procedure in patients with advanced neovascular glaucoma.
The purpose of this study is to conduct a retrospective analysis of clinical objective indicators-including intraocular pressure, medication use, and pain scores-as well as follow-up outcomes in patients with advanced neovascular glaucoma who underwent minimally invasive suprachoroidal drainage surgery. The study aims to evaluate the safety and efficacy of this procedure for advanced neovascular glaucoma. Additionally, it will conduct a retrospective analysis of clinical data from patients with advanced neovascular glaucoma to identify their clinical characteristics.
37 studies on the registry are indexed under Glaucoma, Neovascular; 5 are open to participants now.
Browse Glaucoma, Neovascular studies →Zhongnan Hospital is the lead sponsor of 105 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A group of patients with advanced neovascular glaucoma (approximately 50 individuals) who underwent minimally invasive suprachoroidal drainage surgery at the Department of Ophthalmology, Zhongnan Hospital of Wuhan University, between July 2024 and May 2026
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
intraocular pressure
intraocular pressure(IOP)
Time frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months.
visual acuity
best-corrected visual acuity (BCVA)
Time frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months.
Number of anti-glaucoma medications
number of anti-glaucoma medications
Time frame: Time Frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months.
complications
Complications that may arise during and after surgery, such as haemorrhage into the anterior chamber, vitreous haemorrhage, corneal endothelial decompensation and ocular atrophy, etc.
Time frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months.
NRS
The Numerical Rating Scale (NRS) is a unidimensional pain scale consisting of 11 numbers ranging from 0 to 10, which are used to describe the intensity of pain in incremental steps.
Time frame: Pre-operative (pain scores at baseline) and post-operative (pain scores at the time of the patient's discharge, ranging from 3 to 7 days postoperatively)
Ran from Jul 2024 to primary completion in Apr 2026, 21 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.